Prednisone doses of < 7.5 mg/day are not associated with excess herpes zoster risk

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1281, 2009-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomised, double-blind, comparison of the efficacy and safety of venlafaxine (75 to 150 mg/day) versus fluoxetine (20 mg/day) in depressed outpatients

By Salinas E. Nicholas T. Hackett D.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 308-308

Elsevier

Access to resources Recommend Favorite

Tolerability of Ramipril 10 mg/day in High-Risk Cardiovascular Chinese Patients

By Wu N. Zhu J.R. Chen K.A.

Clinical Drug Investigation, Vol. 22, Iss. 11, 2002-01 ,pp. : 771-781

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Donepezil at Doses up to 20 mg/day: Results from a Pilot Study in Patients with Alzheimer's Disease

By Doody Rachelle S.

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 163-174

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil/prednisone: Disseminated herpes zoster, leading to skin necrosis: case report

Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Herpes Zoster risk increased with DMARDs/oral corticosteroids in RA

Reactions Weekly, Vol. 1, Iss. 1187, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite